Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions

American Journal of Pathology

Volumn 182, Issue 2, 2013, Pages 350-362

  Maliszewska, Agnieszka ^a   Leandro Garcia, Luis J ^a   Castelblanco, Esmeralda ^b,c   Macià, Anna ^d   De Cubas, Aguirre ^a   Goméz López, Gonzalo ^a   Inglada Pérez, Lucía ^a,e   Álvarez Escolá, Cristina ^f   De La Vega, Leticia ^a   Letón, Rocío ^a   Gómez Graña, Álvaro ^a   Landa, Iñigo ^a   Cascón, Alberto ^a,e   Rodríguez Antona, Cristina ^a,e   Borrego, Salud ^e,g   Zane, Mariangela ^h   Schiavi, Francesca ⁱ   Merante Boschin, Isabella ^h   Pelizzo, Maria R ^h   Pisano, David G ^d   Opocher, Giuseppe ^h,i   Matias Guiu, Xavier ^b,c   Encinas, Mario ^a,d   Robledo, Mercedes ^a,e   more..

^a Structural Biology and Biocomputing Programme   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

^c UNIVERSITY OF LLEIDA   (Spain)

^d Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DKK4 PROTEIN; FORMALDEHYDE; GFRA1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; LOXL2 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; PARAFFIN; PROM1 PROTEIN; PROTEIN RET; SMALL INTERFERING RNA; STAT PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; FROZEN SECTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC MARKER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; THYROID MEDULLARY CARCINOMA; TISSUE MICROARRAY; VALIDATION PROCESS;

ANTIGENS, CD; APOPTOSIS; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INHERITANCE PATTERNS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872738914     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.10.025     Document Type: Article

References (53)

1. D. Ball, S.B. Baylin, and A.C. De Butros Medullary thyroid carcinoma L.E. Braverman, R.D. Utiger, Werner and Ingbar's The thyroid 8 ed. 2000 Lippincott Williams & Wilkins Philadelphia 930 943
2. V. Pachnis, B. Mankoo, and F. Costantini Expression of the c-ret proto-oncogene during mouse embryogenesis Development 119 1993 1005 1017
3. C. Eng, D. Clayton, I. Schuffenecker, G. Lenoir, G. Cote, R.F. Gagel, H.K.P. van Amstel, C.J.M. Lips, I. Nishisho, S.I. Takai, D.J. Marsh, B.G. Robinson, K. Frank-Raue, F. Raue, F. Xue, W.W. Noll, C. Romei, F. Pacini, M. Fink, B. Niederle, J. Zedenius, M. Nordenskjold, P. Komminoth, G.N. Hendy, H. Gharib, S.N. Thibodeau, A. Lacroix, A. Frilling, B.A.J. Ponder, and L.M. Mulligan The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis JAMA 276 1996 1575 1579
4. L.M. Mulligan, J.B. Kwok, C.S. Healey, M.J. Elsdon, C. Eng, E. Gardner, D.R. Love, S.E. Mole, J.K. Moore, L. Papi, M.A. Ponder, H. Telenius, A. Tunnacliffe, and B.A. Ponder Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A Nature 363 1993 458 460
5. L. Mulligan, C. Eng, C.S. Healey, D. Clayton, J.B. Kwok, E. Gardner, M.A. Ponder, A. Frilling, C.E. Jackson, H. Lehnert, H.P.H. Neumann, S.N. Thibodeau, and B.A.J. Ponder Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC Nat Genet 6 1994 70 74
6. A. Machens, P. Niccoli-Sire, J. Hoegel, K. Frank-Raue, T.J. van Vroonhoven, H.-D. Roeher, R.A. Wahl, P. Lamesch, F. Raue, B. Conte-Devolx, H. Dralle European Multiple Endocrine Neoplasia (EUROMEN) Study Group Early malignant progression of hereditary medullary thyroid cancer N Engl J Med 349 2003 1517 1525
7. T. Dabir, S. Hunter, C. Russell, D. McCall, and P. Morrison The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma-only phenotype with incomplete penetrance: implications for screening and management of carrier status Fam Cancer 5 2006 201 204
8. R.M. Hofstra, O. Fattoruso, L. Quadro, Y. Wu, A. Libroia, U. Verga, V. Colantuoni, and C.H. Buys A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma J Clin Endocrinol Metab 82 1997 4176 4178
9. M. Drosten, and B.M. Pützer Mechanisms of disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy Nat Clin Pract Oncol 3 2006 564 574
10. Y. Kodama, N. Asai, K. Kawai, M. Jijiwa, Y. Murakumo, M. Ichihara, and M. Takahashi The RET proto-oncogene: a molecular therapeutic target in thyroid cancer Cancer Sci 96 2005 143 148
11. S.J. Marx Molecular genetics of multiple endocrine neoplasia types 1 and 2 [Erratum appeared in Nat Rev Cancer 2005, 5:663] Nat Rev Cancer 5 2005 367 375
12. E. Arighi, M.G. Borrello, and H. Sariola RET tyrosine kinase signaling in development and cancer Cytokine Growth Factor Rev 16 2005 441 467
13. T. Weber, T. Schilling, and M.W. Büchler Thyroid carcinoma Curr Opin Oncol 18 2006 30 35
14. L. Cooley, F.F. Elder, A. Knuth, and R.F. Gagel Cytogenetic characterization of three human and three rat medullary thyroid carcinoma cell lines Cancer Genet Cytogenet 80 1995 138 149
15. M. Santoro, F. Carlomagno, A. Romano, D.P. Bottaro, N.A. Dathan, M. Grieco, A. Fusco, G. Vecchio, B. Matoskova, M.H. Kraus, and P.P. Di Fiore Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B Science 267 1995 381 383
16. M. Ritchie, J. Silver, A. Oshlack, M. Holmes, D. Diyagamam, A. Holloway, and G.K. Smyth A comparison of background correction methods for two-colour microarrays Bioinformatics 23 2007 2700 2707
17. G.K. Smyth, J. Michaud, and H.S. Scott Use of within-array replicate spots for assessing differential expression in microarray experiments Bioinformatics 21 2005 2067 2075
18. D. Montaner, J. Tárraga, J. Huerta-Cepas, J. Burguet, J.M. Vaquerizas, L. Conde, P. Minguez, J. Vera, S. Mukherjee, J. Valls, M.A. Pujana, E. Alloza, J. Herrero, F. Al-Shahrour, and J. Dopazo Next station in microarray data analysis: GEPAS Nucleic Acids Res 34 Web Server issue 2006 W486 W491
19. M. Reich, K. Ohm, M. Angelo, P. Tamayo, and J.P. Mesirov GeneCluster 2.0: an advanced toolset for bioarray analysis Bioinformatics 20 2004 1797 1798
20. E.R. Morrissey, and R. Diaz-Uriarte Pomelo II: finding differentially expressed genes Nucleic Acids Res 37 Web Server issue 2009 W581 W586
21. Y. Benjamini, D. Drai, G. Elmer, N. Kafkafi, and I. Golani Controlling the false discovery rate in behavior genetics research Behav Brain Res 125 2001 279 284
22. F. Al-Shahrour, R. Diaz-Uriarte, and J. Dopazo FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes Bioinformatics 20 2004 578 580
23. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci USA 102 2005 15545 15550
24. X. Dolcet, D. Llobet, M. Encinas, J. Pallares, A. Cabero, J.A. Schoenenberger, J.X. Comella, and X. Matias-Guiu Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants J Biol Chem 281 2006 22118 22130
25. G. Cuccuru, C. Lanzi, G. Cassinelli, G. Pratesi, M. Tortoreto, G. Petrangolini, E. Seregni, A. Martinetti, D. Laccabue, C. Zanchi, and F. Zunino Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma J Natl Cancer Inst 96 2004 1006 1014
26. L. Gorla, P. Mondellini, G. Cuccuru, F. Miccichè, G. Cassinelli, M. Cremona, M.A. Pierotti, C. Lanzi, and I. Bongarzone Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements Mol Carcinog 48 2009 220 231
27. P. Gallel, J. Pallares, X. Dolcet, D. Llobet, N. Eritja, M. Santacana, A. Yeramian, V. Palomar-Asenjo, H. Lagarda, D. Mauricio, M. Encinas, and X. Matias-Guiu Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma Hum Pathol 39 2008 994 1001
28. N. Ameur, L. Lacroix, S. Roucan, V. Roux, S. Broutin, M. Talbot, C. Dupuy, B. Caillou, M. Schlumberger, and J.M. Bidart Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways Endocr Relat Cancer 16 2009 1261 1272
29. Y. Deng, G. Nagae, Y. Midorikawa, K. Yagi, S. Tsutsumi, S. Yamamoto, K. Hasegawa, N. Kokudo, H. Aburatani, and A. Kaneda Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma Cancer Sci 101 2010 1501 1510
30. A. Zacharias, and P.J. Gage Canonical Wnt/beta-catenin signaling is required for maintenance but not activation of Pitx2 expression in neural crest during eye development Dev Dyn 239 2010 3215 3225
31. P. Steiner, K. Kulangara, J.C.F. Sarria, L. Glauser, R. Regazzi, and H. Hirling Reticulon 1-C/neuroendocrine-specific protein-C interacts with SNARE proteins J Neurochem 89 2004 569 580
32. M. Ohiwa, H. Murakami, T. Iwashita, N. Asai, Y. Iwata, T. Imai, H. Funahashi, H. Takagi, and M. Takahashi Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations Biochem Biophys Res Commun 237 1997 747 751
33. M. Schlumberger, F. Carlomagno, E. Baudin, J.M. Bidart, and M. Santoro New therapeutic approaches to treat medullary thyroid carcinoma Nat Clin Pract End Met 4 2008 22 32
34. R. Khurana, A. Agarwal, V.K. Bajpai, N. Verma, A.K. Sharma, R.P. Gupta, and K.P. Madhusudan unraveling the amyloid associated with human medullary thyroid carcinoma Endocrinology 145 2004 5465 5470
35. T. Watanabe, M. Ichihara, M. Hashimoto, K. Shimono, Y. Shimoyama, T. Nagasaka, Y. Murakumo, H. Murakami, H. Sugiura, H. Iwata, N. Ishiguro, and M. Takahashi Characterization of gene expression induced by RET with MEN2A or MEN2B mutation Am J Pathol 161 2002 249 256
36. T. Musholt, J. Hanack, C. Brehm, R. von Wasielewski, and P.B. Musholt Searching for non-RET molecular alterations in medullary thyroid carcinoma: expression analysis by mRNA differential display World J Surg 29 2005 472 482
37. L. Lacroix, V. Lazar, S. Michiels, H. Ripoche, P. Dessen, M. Talbot, B. Caillou, J.P. Levillain, M. Schlumberger, and J.M. Bidart Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations Am J Pathol 167 2005 223 231
38. S. Jain, M.A. Watson, M.K. DeBenedetti, Y. Hiraki, J.F. Moley, and J. Milbrandt Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors Cancer Res 64 2004 3907 3913
39. R. Tofighi, B. Joseph, S. Xia, Z.Q. Xu, B. Hamberger, T. Hökfelt, and S. Ceccatelli Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2) Proc Natl Acad Sci USA 105 2008 2717 2722
40. A. Berger, R. Santic, C. Hauser-Kronberger, F.H. Schilling, P. Kogner, M. Ratschek, A. Gamper, N. Jones, W. Sperl, and B. Kofler Galanin and galanin receptors in human cancers Neuropeptides 39 2005 353 359
41. J.J. Hawes, R. Narasimhaiah, and M.R. Picciotto Galanin and galanin-like peptide modulate neurite outgrowth via protein kinase C-mediated activation of extracellular signal-related kinase Eur J Neurosci 23 2006 2937 2946
42. T. Sugimoto, N. Seki, S. Shimizu, N. Kikkawa, J. Tsukada, H. Shimada, K. Sasaki, T. Hanazawa, Y. Okamoto, and A. Hata The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma Genes Chromosomes Cancer 48 2009 132 142
43. A. Machens, M. Brauckhoff, H.J. Holzhausen, P.N. Thanh, H. Lehnert, and H. Dralle codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2 J Clin Endocrinol Metab 90 2005 3999 4003
44. O. Gimm, H. Dziema, J. Brown, C. Hoang-Vu, R. Hinze, H. Dralle, L.M. Mulligan, and C. Eng Over-representation of a germline variant in the gene encoding RET co-receptor GFR alpha-1 but not GFR alpha-2 or GFR alpha-3 in cases with sporadic medullary thyroid carcinoma Oncogene 20 2001 2161 2170
45. A. Matsui, T. Yamaguchi, S. Maekawa, C. Miyazaki, S. Takano, T. Uetake, T. Inoue, M. Otaka, H. Otsuka, T. Sato, A. Yamashita, Y. Takahashi, and N. Enomoto DICKKOPF-4 and -2 genes are upregulated in human colorectal cancer Cancer Sci 100 2009 1923 1930
46. B. Mao, and C. Niehrs Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling Gene 302 2003 179 183
47. F. Rückert, P. Joensson, H.D. Saeger, R. Grützmann, and C. Pilarsky Functional analysis of LOXL2 in pancreatic carcinoma Int J Colorectal Dis 25 2010 303 311
48. L. Peng, Y.L. Ran, H. Hu, L. Yu, Q. Liu, Z. Zhou, Y.M. Sun, L.C. Sun, J. Pan, L.X. Sun, P. Zhao, and Z.H. Yang Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway Carcinogenesis 30 2009 1660 1669
49. H. Peinado, G. Moreno-Bueno, D. Hardisson, E. Pérez-Gómez, V. Santos, M. Mendiola, J.I. de Diego, M. Nistal, M. Quintanilla, F. Portillo, and A. Cano Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas Cancer Res 68 2008 4541 4550
50. H. Peinado, M. Del Carmen Iglesias-de la Cruz, D. Olmeda, K. Csiszar, K.S. Fong, S. Vega, M.A. Nieto, A. Cano, and F. Portillo A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression EMBO J 24 2005 3446 3458
51. W. Zhu, T. Hai, L. Ye, and G.J. Cote Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity J Clin Endocrinol Metab 95 2010 439 444
52. A. Raso, S. Mascelli, R. Biassoni, P. Nozza, M. Kool, A. Pistorio, E. Ugolotti, C. Milanaccio, S. Pignatelli, M. Ferraro, M. Pavanello, M. Ravegnani, A. Cama, M.L. Garrè, and V. Capra High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma Neuro Oncol 13 2011 500 508
53. M. Cook, X.M. Yu, and H. Chen Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer Am J Transl Res 2 2010 119 125